Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis
Open Access
- 26 May 2017
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 282 (1) , 64-75
Abstract
Imbalance in the autonomic nervous system (ANS) has been observed in many established chronic autoimmune diseases, including rheumatoid arthritis (RA), which is a prototypic immune‐mediated inflammatory disease (IMID). We recently discovered that autonomic dysfunction precedes and predicts arthritis development in subjects at risk of developing seropositive RA. In addition, RA patients with relatively high vagus nerve tone (higher parasympathetic parameters, measured by heart rate variability) respond better to antirheumatic therapies. Together, these data suggest that the ANS may control inflammation in humans. This notion is supported by experimental studies in animal models of RA. We have found that stimulation of the so‐called cholinergic anti‐inflammatory pathway by efferent electrical vagus nerve stimulation (VNS) or pharmacological activation of the alpha7 subunit of nicotinic acetylcholine receptors (α7nAChR) improves clinical signs and symptoms of arthritis, reduces cytokine production and protects against progressive joint destruction. Conversely, increased arthritis activity was observed in alpha7nAChR knockout mice. These studies together with previous work in animal models of sepsis and other forms of inflammation provided the rationale for an experimental clinical trial in patients with RA. We could for the first time show that an implantable vagus nerve stimulator inhibits peripheral blood cytokine production in humans. VNS significantly inhibited TNF and IL‐6 production and improved RA disease severity, even in some patients with therapy‐resistant disease. This work strongly supports further studies using a bioelectronic approach to treat RA and other IMIDs.Keywords
This publication has 106 references indexed in Scilit:
- Smoking and overweight determine the likelihood of developing rheumatoid arthritisAnnals of the Rheumatic Diseases, 2013
- Neural reflexes in inflammation and immunityJournal of Experimental Medicine, 2012
- EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid ArthritisAnnals of the Rheumatic Diseases, 2012
- Nicotine‐induced differential modulation of autoimmune arthritis in the Lewis rat involves changes in interleukin‐17 and anti–cyclic citrullinated peptide antibodiesArthritis & Rheumatism, 2011
- Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritisJournal of Internal Medicine, 2010
- Selective α7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitisBritish Journal of Pharmacology, 2010
- Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson DiseaseA Randomized Controlled TrialJAMA, 2009
- Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsisJournal of Experimental Medicine, 2006
- Evolving concepts of rheumatoid arthritisNature, 2003
- Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammationNature, 2002